STO Medical Services has recently hosted a conference aimed at raising awareness on chronic kidney disease, diabetes, and cardiac conditions.
The event highlighted the recent approval by the US FDA of a medication imported and distributed by STO from AstraZeneca. This medication is designed to improve glycemic control in children aged 10 years and older with type-2 diabetes.
The conference also underscored the importance of managing type-2 diabetes and introduced the latest globally approved medications for treating cardio, renal, and metabolic diseases related to diabetes.
The event saw attendance of over 100 healthcare professionals from the Maldives, and featured presentations from several esteemed doctors that included Dr. Mohamed Shiruhan, Dr. Ibrahim Shiham, and Dr. Shaneez Najmy.
These distinguished speakers shared their extensive knowledge and expertise in treating chronic kidney, disease, diabetes, and cardiac conditions, including heart failure.
Additionally, Dr. Sanjay Katra, Chairperson of the Education Working Group of ISE, addressed the attendees, offering his insight on glycemic control in type-2 diabetes management.
